Journal publications and recommended reads
Journal articles by CTRad members
The CTRad Executive Group and members published several journal articles and editorials to provide guidance and comments on radiotherapy-specific topics.
Hanna CR, Lynskey DM, Wadsley J, et al. Radiotherapy Trial Set-up in the UK: Identifying Inefficiencies and Potential Solutions. Clin Oncol (R Coll Radiol) 2019 (Available online 1 November 2019; in press corrected proof).
Chalmers AJ, Chan C, Sebag-Montefiore D on behalf of the Executive Group of the National Cancer Research Institute’s Clinical and Translational Radiotherapy Research Working Group (CTRad). CTRad 10 Years On: From 10-point Plan to Top 10 Achievements. Clin Oncol (R Coll Radiol) 2019 (Available online 19 September 2019; in press corrected proof).
Falzone N, Gregory R, Aldridge M, et al. Commentary: Clinical trials in molecular radiotherapy—Tribulations and Triumphs Report of the NCRI CTRad meeting held at the Lift Islington, 8 June 2018. Br J Radiol 2019;10.1259/bjr.20190117.
National Cancer Research Institute Clinical and Translational Radiotherapy Research Working Group (CTRad) Proton Beam Clinical Trial Strategy Group. Proton Beam Therapy – the Challenges of Delivering High-quality Evidence of Clinical Benefit. Clin Oncol (R Coll Radiol) 2018;30(5):280-4.
Williams KJ, Buckley DL, Jones GDD. Establishment of the National Cancer Research Institute Clinical and Translational Radiotherapy Research Working Group (CTRad) Biomarker Support Network. Clin Oncol (R Coll Radiol) 2014;26(6):365.
Burnet NG. Rapid response, ‘Proton beam therapy for cancer: An important development for patients, with an explicit research agenda’ to ‘Is spending on proton beam therapy for cancer going too far, too fast?’. [letter to the editor] BMJ available from http://www.bmj.com/content/344/bmj.e2488/rr/581410 (last accessed March 2014)
Recommended reads from CTRad members
Ataman OU, Sambrook SJ, Wilks C, et al. The Clinical Development of Molecularly Targeted Agents in Combination With Radiation Therapy: A Pharmaceutical Perspective. Int J Radiat Oncol Biol Phys 2012;84(4):e447–54.